2024 International Congress » Parkinson's Disease: Pathophysiology

Meeting: 2024 International Congress

A pathology-validated study to investigate the role of Uric Acid in Parkinson’s Disease

P. Pecoraro, S. Carbone, V. Di Lazzaro, L. Di Biase (Rome, Italy)

A Risk of Thromboembolic Complications In Patients With Parkinson’s Disease

P. Lisewski, B. Lisewska, N. Słomka, M. Wasilewska, D. Rość (Bydgoszcz, Poland)

Age-associated Changes in Microglial Morphology and its Role in Deciphering Susceptibility to Parkinson’s Disease

S. Choudhury, P. Abhilash, P. Alladi (Bengaluru, India)

Alpha-synuclein aggregate pathology in the cranial sensorimotor system in a mouse model of Parkinson’s disease.

A. Schaser (West Lafayette, USA)

Alterations in Monoamine Metabolites in Parkinson’s Disease: A Meta-Analysis

MA. Muneer, V. Suresh, E. Zulfiqar, S. Saaki, I. Jaffery, V. Chowdary, S. Hurjkaliani (Lahore, Pakistan)

Altered gut microbiota composition and metabolism in Parkinson’s disease

D. Mondhe, K. Roper, N. Jayabalan, J. O'Sullivan, R. Adam, A. Lehn, R. Gordon (Brisbane, Australia)

Assessing the Predictive Accuracy of Baseline Neuropsychiatric and Axial Motor Features for Freezing of Gait in Parkinson’s Disease at 5-year Follow up: The PPMI Cohort

J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

Association Between Glycated Hemoglobin (HbA1c) Levels And Motor Symptoms In Indian Subjects With Parkinson’s Disease: A Cross Sectional Observational Study

NIK. Choudhary, NAV. Seervi, AMI. Bhargava, SHU. K (Jodhpur, India)

Climate Change Indices and The Vulnerability of Parkinson’s Patients in The MENA Region And North Africa: A Narrative Review

MYA. Amine, F. Essam (Giza, Egypt)

Deep Brain Stimulators in Parkinson`s subthalamic nucleus: A Study of Decade Follow-Up

L. Neerati, V. Raju, G. Ramaraju (Hyderabad, India)

Determining Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical Data

C. Venuto, K. Herbst, K. Kieburtz (Rochester, USA)

Differentiating the Local Field Potential Oscillations in Low and Beta Range in Parkinson`s and Dystonic Movement Disorder

S. Konda, R. Venkateshwara, K. Balmuri (Hyderabad, India)

Do Proton Pump Inhibitors Increase the Risk of Parkinson’s Disease? A systematic review and meta-analysis

S. Karki, A. Parajuli (Kathmandu, Nepal)

Effectiveness of Lead-Point in Parkinson`s Model of STN-MER with DBS: A Study of Predicting Motor progression

V. Rama Raju (Hyderabad, India)

Effects of Sample Collection Methods on Skin Sebum Volatilome Composition in Parkinson’s Disease Patients – a Methodological Pilot Study

V. van Midden, L. Strojnik, M. Mencin, N. Ogrinc, M. Kojović (Ljubljana, Slovenia)

Enviromental Risk Factors for Parkinson’s Disease in the Nigeria Parkinson’s Disease Research Network

N. Obianozie, O. Ojo, 0. Agabi, N. Okubadejo, N. Research Network (Abuja, Nigeria)

Exploring the Therapeutic Potential of Microglial Modulation in Parkinson’s Disease: A Study on Structural Synaptic Plasticity

F. Fares Taie, I. Taravini, L. Rela (Buenos Aires, Argentina)

Eye Blink Rate and Putamen DaTScan Covariation in Parkinson’s Disease

Q. Salardaine, V. Vasudevan, N. Villain, E. Biondetti, S. Lehéricy, M. Vidailhet, P. Pouget (Paris, France)

Genetic Variants and Levodopa Response in Parkinson’s Disease: Insights from MAO-B and DAT1 Polymorphisms

S. Sarkar, A. Biswas, S. Ansari, S. Sengupta, S. Choudhury, R. Banerjee, S. Chatterjee, S. Dey, H. Kumar (Kolkata, India)

Harnessing chaperone-mediated autophagy through viral-based LAMP2A overexpression in non-human primates as a Treatment of Parkinson’s Disease

ML. Arotcarena, M. Fouka, E. Gialinaki, L. Stefanis, E. Bezard, M. Xilouri, B. Dehay (BORDEAUX, France)

Impact of sub-acute MPTP exposure on the cerebellum in adult male Balb/c mice

F. Sulaimon, R. Ibiyeye, R. Adeniyi, Y. Jimoh, M. Awodola, T. Adeoye, M. Shehu (Ilorin, Nigeria)

IPSC-derived Cortical Neurons from Parkinson’s Patients with VPS35 Mutation show Defects in Synapto- and Neurogenesis

U. Scheller, CK. Lee, P. Seibler, M. Mitkovski, JS. Rhee, C. van Riesen (Goettingen, Germany)

Levels of ferritinemia in Parkinson’s disease patients who underwent Covid-19

B. Amonov, R. Matmurodov, B. Muminov (Tashkent, Uzbekistan)

Lower Incidence of Parkinson’s Disease in Patients with Metabolic Syndrome or any of its Components: A Longitudinal Study

R. Djaldetti, H. Avisar, U. Greenbaum, B. Lerner (Petah Tiqva, Israel)

Muscle Augmentation Paradox: Contrasting Therapeutic Approaches in Myasthenia Gravis and Parkinson’s Disease

G. Legerme, D. Nolasco, A. Sohel, A. Wu, B. Carr (Gainesville, USA)

Neuropeptide Alterations in Parkinson’s Disease: A Meta-Analysis

MA. Muneer, V. Suresh, S. Aujla, A. Khare, P. Gowda, V. Ghosh, T. Dave (Lahore, Pakistan)

Neuroprotective Action of Exogenous Melatonin in Parkinson Disease Patients and its Impact on Daily Routine: a Systematic Review

G. Maia, P. Silva, M. Rosa, R. Albuquerque, E. Almeida, C. Menegon, V. Serafim, F. Oliveira, G. Sorato, I. Fink, C. Rieder (Porto Alegre, Brazil)

Phenotypic characterization of an ATP13A2 knockout rat model of Parkinson’s disease

R. Kinet, J. Sikora, ML. Arotcarena, M. Decourt, E. Balado, E. Doudnikoff, E. Bezard, PO. Fernagut, B. Dehay (BORDEAUX, France)

Plasma biomarkers for rapid eye movement sleep behavior disorder in Parkinson’s disease: a prospective cohort study

J. Lin, C. Li, R. Ou (Chengdu, China)

Predictive Accuracy of Baseline DaT-SPECT for Freezing of Gait at 5, 7, and 10-year Follow up in The PPMI Cohort

J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

Pregnancy and delivery in women with Parkinson’s disease: A case series

W. Kapelle, A. Oosterbaan, G. Patané, C. Piat, K. Ghoniem, E. Camerucci, P. Turcano, J. Bower, R. Savica (Rochester, USA)

Prokineticin-2 is highly expressed in colonic mucosa of early Parkinson’s disease patients

G. Bellini, G. Palermo, F. Rettura, E. Del Prete, E. Unti, C. Ippolito, C. Pellegrini, D. Frosini, N. Bernardini, R. Ceravolo (Pisa, Italy)

Putaminal dopamine modulates movement motivation in Parkinson’s disease

M. Banwinkler, V. Dzialas, L. Rigoux, H. Theis, A. Asendorf, K. Giehl, M. Tittgemeyer, M. Hoenig, T. van Eimeren (Cologne, Germany)

Reduced plasma levels of various cell signaling molecules in patients with Parkinson’s Disease

S. Zadegan, A. Teixeira, E. Furr Stimming, N. Pessoa Rocha (Housotn, USA)

Sexual Dimorphism in Clinical Subtypes, Biomarkers and Disease Progression of Parkinson’s Disease

SM. Fereshtehnejad, H. Azizi, J. Lökk, Y. Zeighami (Toronto, Canada)

Study of Cytokine profile in a Tunisian Parkinson’s Disease cohort

O. Ben Othman, S. Frikha, S. Fezai, A. Achouri, M. Ben Mahmoud, H. Jamoussi, S. Fray, M. Fredj, N. Ben Ali (Tunis, Tunisia)

The Inhibition of Mitochondrial NLRP3 Inflammasome Decreases Dopaminergic Cell Death in a 6-OHDA Mouse Model of Parkinson’s Disease.

E. Dalle, O. Ondoua Nguele, H. Bayaga (Yaounde, Cameroon)